Akadeum Life Sciences Overview
- Founded
-
2014
- Status
-
Private
- Employees
-
27
- Latest Deal Type
-
2ndary - Private
- Investors
-
30
Akadeum Life Sciences General Information
Description
Developer of bio-separation products designed to facilitate the removal of target cells from biological samples. The company's products are based on buoyancy-activated cell sorting that uses microscopic micro-bubbles to capture target cells and quickly float them to the surface of a liquid sample for removal, enabling medical practitioners to use those cells for performing downstream testing and analysis with increased efficiency.
Contact Information
Website
www.akadeum.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Devices and Supplies
Primary Office
- 674 South Wagner Road
- Ann Arbor, MI 48103
- United States
+1 (734) 000-0000
Akadeum Life Sciences Timeline
Akadeum Life Sciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Secondary Transaction - Private | 22-Feb-2022 | 000.00 | Completed | Generating Revenue | ||
| 8. Later Stage VC (Series B) | 12-Oct-2021 | 000.00 | 000.00 | 000.00 | Completed | Generating Revenue |
| 7. Later Stage VC (Series A) | 11-May-2020 | 00.000 | 00.000 | 0000 | Completed | Generating Revenue |
| 6. Early Stage VC (Series A1) | 01-Feb-2019 | 000 | 00.000 | 00.00 | Completed | Generating Revenue |
| 5. Seed Round | 28-Sep-2017 | 00.000 | 00.000 | 00.000 | Completed | Startup |
| 4. Seed Round | 31-Jul-2015 | 000 | 00.000 | 00.00 | Completed | Startup |
| 3. Seed Round | 21-Oct-2014 | 00000 | 00000 | Completed | Startup | |
| 2. Accelerator/Incubator | Completed | Startup | ||||
| 1. Grant | 01-Mar-2014 | $50K | Completed | Startup |
Akadeum Life Sciences Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | 00,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
| Series B-2 | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 0.000 |
| Series B-1 | 00,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 0.000 |
| Series A-1 | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 0.00 |
| Series A | 00,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 0.000 |
| Seed Prime | 5,492,508 | $0.001000 | $0.03 | $0.33 | $0.33 | 1x | $0.33 | 2.59% |
| Seed | 3,627,200 | $0.001000 | $0.02 | $0.29 | $0.29 | 1x | $0.29 | 1.71% |
Akadeum Life Sciences Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of bio-separation products designed to facilitate the removal of target cells from biological samples. The com
Biotechnology
Ann Arbor, MI
27
As of 2022
000.00
00000000000
000.00
000000
m, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irur
0000000000000
Menlo Park, CA
00
As of 0000
0000
000000000
0000
000000
ostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor i
0000000000000
Vancouver, Canada
0000
As of 0000
000.00
00000000. 00
000.00
Add Comparison
Akadeum Life Sciences Competitors (26)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| LevitasBio | Venture Capital-Backed | Menlo Park, CA | 00 | 0000 | 000000000 | 0000 |
| 00000000 000000000 | Private Debt Financed | Vancouver, Canada | 0000 | 000.00 | 00000000. 00 | 000.00 |
| 000000 | Formerly VC-backed | Ann Arbor, MI | 00 | 000.00 | 000000&0 | 000.00 |
| 00000000 0000000 0 | Formerly VC-backed | Castel Maggiore, Italy | 00000 | 000.00 | 000000&0 | 000.00 |
| 00000000 000000000 | Venture Capital-Backed | Pessac, France | 00 | 000.00 | 00000000000 | 000.00 |
Akadeum Life Sciences Patents
Akadeum Life Sciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3820588-A1 | System and method for buoyant particle processing | Pending | 09-Jul-2018 | 0000000000 | |
| JP-2021530226-A | Systems and methods for treating suspended particles | Pending | 09-Jul-2018 | 0000000000 | 0 |
| US-20200009614-A1 | System and method for buoyant particle processing | Abandoned | 09-Jul-2018 | 000000000 | |
| EP-3820588-A4 | System and method for buoyant particle processing | Pending | 09-Jul-2018 | 000000000 | 0 |
| US-20220176407-A1 | System and method for buoyant particle processing | Pending | 09-Jul-2018 | C12M25/16 |
Akadeum Life Sciences Executive Team (9)
Akadeum Life Sciences Board Members (7)
| Name | Representing | Role | Since |
|---|---|---|---|
| Brock Siegel Ph.D | Akadeum Life Sciences | Board Member & Chief Operating Officer | 000 0000 |
| Dan Kidle | Self | Board Member | 000 0000 |
| Douglas Neal | eLab Ventures | Board Observer | 000 0000 |
| John Bonhard | Beringea | Board Observer | 000 0000 |
| William Hyun Ph.D | Self | Board Member | 000 0000 |
Akadeum Life Sciences Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Akadeum Life Sciences Investors (30)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Arboretum Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
| ArgoPond | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Beringea | Venture Capital | Minority | 000 0000 | 000000 0 | |
| BlueStone Venture Partners | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Lifespan Investments | Venture Capital | Minority | 000 0000 | 000000 0 |